Site Search
Search Results
Steps Governor Hochul Can Take to Make New York a Leader in Health Equity
... years. New York has seen declines in both cancer incidence and mortality from breakthroughs in research and treatment, but there is still a lot of work to be done. If New York aims to remain a national leader in cancer care, as I believe the Empire State is meant to be, our elected ... and diagnostic services. In this, Governor Hochul has the opportunity to make New York a health equity champion. There are steps she can take now as well as in the coming year to ensure equitable and impactful policy becomes law. Let’s walk through them, starting with actions ... two bipartisan bills limiting New Yorkers’ out-of-pocket health expenses. The first, A2085-A / S906-B, or the Colorectal Cancer Screening Cost Sharing Removal Act, requires that every state-regulated health plan covers 100% of the cost of colorectal cancer screening beginning at age ...
Governor Hochul Signs Game-Changing Legislation Aimed at Improving Health Outcomes, Quality of Life for New Yorkers
... including Medicaid, to cover comprehensive biomarker testing, which will enable more New Yorkers to access precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for patients facing cancer and other serious illnesses. “ACS CAN is proud to see New York, a longstanding ... equity and medical innovation, join thirteen other states that have recently enacted similar legislation,” said Lisa Lacasse, President of ACS CAN. “This action ensures that New York will continue to pave the way in the fight against cancer and improve access to the most effective ...
Colorectal Cancer Awareness Month 2023: What Has New York Done to Address Rise in Colorectal Cancer Diagnoses?
DUTCHESS COUNTY, NY – MARCH 28, 2023 – At the start of Colorectal Cancer (CRC) Awareness Month, the American Cancer Society (ACS) released their report “Colorectal Cancer Facts & Figures ... for patients with cancer and other diseases by expanding access to biomarker testing. Building off the progress of the Colorectal Cancer Cost-Sharing Removal Act, which was passed at the end of 2022 and will remove financial barriers to screening, Senate Bill 1196 / Assembly Bill ... resources—and the hope such resources bring,” said Peter, who is remission as of January 2023. Insight gained from biomarker testing can be used to help guide medical treatment in CRC as well as other cancers and diseases. Biomarker testing is often used to connect patients with ...
Oncologists to Visit New York State Capitol & Urge Legislators to Improve Access to Biomarker Testing
... York will gather at the Capitol building on Wednesday, May 17 to answer lawmakers’ questions about biomarker testing and ask for their support of Senate Bill 1196 / Assembly Bill 1673, which aim to improve New Yorkers’ access to biomarker testing – a tool that opens the door to ... Testing: Opportunity to Revolutionize Cancer Care in New York WHO: Oncologists, cancer survivors and patient advocates representing ACS CAN to host press conference on biomarker testing legislation WHERE: New York State Capitol, Floor 3, Hallway between Senate Lobby & LCA Press ... testing with her survivorship following a pediatric metastatic thyroid diagnosis, as well as mother-daughter duo Mary and Charlotte Carlin, both of whom benefitted from biomarker testing throughout their respective cancer journeys with Charlotte undergoing the lifesaving testing at just 6 ...
Texas Becomes Latest State to Improve Access to Biomarker Testing, Beating New York in Push to Prioritize Precision Medicine
... York is considering comparable legislation through Assembly Bill 1673 / Senate Bill 1196. The American Cancer Society Cancer Action Network (ACS CAN) Senior Government Relations Director in New York, Michael Davoli, responded to the legislative victory in Texas with the following statement: “Texas has joined a growing list of states expanding access to biomarker testing. The clock is ticking for New York to do the same. We cannot wait any longer to act on Assembly ... must prioritize legislation such as Assembly Bill 1673 / Senate Bill 1196. In doing so, we can work to improve health outcomes, patient quality of life and—in some cases—reduce costs. “The victory in Texas should be eye-opening to legislators across New York; we need to make precision ...
Legislation Aimed at Improving Health Outcomes for New Yorkers Heads to Governor Hochul’s Desk
... / Assembly Bill 1673a to the Governor’s desk, giving her 10 days to take action on the legislation. Their proposal aims to ensure millions of New Yorkers can access precision care by requiring all state-regulated health plans to cover comprehensive biomarker testing. Biomarker testing opens the door to treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for patients. Advocates are hopeful that Governor Hochul will sign the legislation without any amendments to ...
New York State Senate Votes to Remove Barriers to Biomarker Testing
... Medicaid, when patients need it. This legislative victory came several hours after the American Cancer Society Cancer Action Network (ACS CAN) hosted cancer patients and survivors at the Capitol to honor National Cancer Survivors Day. Biomarker testing has revolutionized cancer treatment over the last few decades and is increasingly important in the treatment of other conditions, providing access to targeted treatment and tailoring care to a person’s individual disease. Targeted therapies often result in improved quality of life and survivorship. For example, patients with certain lung cancer types who received biomarker testing and then a targeted therapy saw a 31% ...
Calls to Improve New Yorkers’ Access to Precision Medicine Through Biomarker Testing Bring Together Patients and Providers from across Disease Spectrum
... to cover biomarker testing when it is supported by medical and scientific evidence. Over 60 organizations have rallied together in support of the legislation, citing the efficacy of and praising the innovation in precision medicine. Biomarker testing is a tool utilized by physicians ... medicine, or personalized care. Biomarker testing helps providers to identify the most appropriate treatment for a disease. In cancer care, this can enable patients to receive targeted therapies and is often used in determining a patient’s eligibility for participation in clinical trials. ... care to the patients we serve, Northwell created a Center for Genomic Medicine to deliver these innovative approaches as rapidly and cost-effectively as possible, partnering expertise in cancer molecular diagnostics with oncology physicians to improve cancer outcomes in real ...
Patient Advocates Rally in Times Square for New Yorkers’ Access to Precision Medicine, Urge Governor Hochul to Sign Biomarker Testing Legislation
... – Earlier today, cancer survivors gathered in Times Square alongside health care providers and patient advocates to emphasize the importance of biomarker testing for the health of New York State, its people and its potential for an equitable, hope-filled future. Attendees of the rally called on Governor Hochul to sign ... passed the Legislature in June with support from over 65 patient and provider groups. For American Cancer Society Cancer Action Network (ACS CAN) volunteer Mary Carlin, the effort to improve access to biomarker testing is personal. Not only did she benefit from biomarker testing during ...
Oncologists Call for Improvements in Access to Biomarker Testing as Assembly Insurance Committee Signals Unanimous Support
... cancer survivors from across New York gathered at the Capitol to answer lawmakers’ questions about biomarker testing and ask for their support of Senate Bill 1196 / Assembly Bill 1673. This legislation, which is being sponsored by Asm. Pamela Hunter and Sen. Roxanne Persaud and maintains ... aims to improve New Yorkers’ access to precision medicine through biomarker testing. Biomarker testing has become a game-changing part of cancer care given its role in opening the door to targeted treatments that can lead to improved survivorship and quality of life. Despite the proven benefits, some insurers are failing to keep pace with innovations and ...